Compare FTK & THW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FTK | THW |
|---|---|---|
| Founded | 1985 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Finance Companies |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 522.1M | 513.9M |
| IPO Year | 1997 | 2015 |
| Metric | FTK | THW |
|---|---|---|
| Price | $18.48 | $12.17 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $20.00 | N/A |
| AVG Volume (30 Days) | ★ 224.8K | 133.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 440.00 | N/A |
| EPS | ★ 0.78 | N/A |
| Revenue | ★ $136,092,000.00 | N/A |
| Revenue This Year | $5.39 | N/A |
| Revenue Next Year | $9.82 | N/A |
| P/E Ratio | $22.17 | ★ N/A |
| Revenue Growth | ★ 214.53 | N/A |
| 52 Week Low | $6.05 | $9.80 |
| 52 Week High | $20.09 | $13.19 |
| Indicator | FTK | THW |
|---|---|---|
| Relative Strength Index (RSI) | 57.83 | 39.09 |
| Support Level | $14.11 | $11.80 |
| Resistance Level | $18.58 | $13.00 |
| Average True Range (ATR) | 1.25 | 0.20 |
| MACD | 0.14 | -0.04 |
| Stochastic Oscillator | 91.80 | 26.37 |
Flotek Industries Inc is a technology-driven specialty chemistry and data company. It has two reportable segments: Its Chemistry Technologies segment includes specialty chemistries, logistics and technology services. It also include integrated oil and gas companies, oilfield services companies, independent oil and gas companies, national and state-owned oil companies, and international supply chain management companies. The Data Analytics segment provides analytical measurement solutions and deliver real-time information and insights to customers to enable optimization of operations and reduction of emissions and their carbon intensity. Key revenue comes from its Chemistry Technologies segment.
Tekla World Healthcare Fund is a diversified closed-end management investment company. Its investment objective is to seek current income and long-term capital appreciation. The Fund mainly invests in equity and debt securities of public and private U.S. and non-U.S. companies that the Fund's investment adviser believes have the potential for above-average growth. The company's investment portfolio includes holdings across various sub-sectors such as pharmaceuticals and biotechnology, healthcare providers and services, real estate investment trusts, medical devices and diagnostics, and other related areas.